About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT06758960

Analysis of Biological Progression and Regression of HELLP Syndrome in Time

Prospective observational study about progression and regression of biological parameters of HELLP syndrome

Lead sponsor: CHU Mohammed VI Marrakech•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

CHU Mohammed VI Marrakech

Data collection included a comprehensive review of pathological histories, identification of complications based on clinical presentation, daily monitoring of biological parameters, documentation of transfusion events, recording of corticosteroid administration according to gestational age, and detailed reporting of extraction and analgesia techniques.

Age

All ages

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Pregnant women who are admitted to the maternal ICU for a biological HELLP syndrome

Exclusion Criteria

•Patients whose biological presentation was attributable to other conditions, such as microangiopathies or leukemia.
•Patients who benefited from plasma exchange therapy

Related studies

RECRUITINGPhase 3

PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

NCT06033131 · Preeclampsia

The Combined First Trimester Screening

NCT07015203 · Preeclampsia (PE), Fetal Growth Restriction, and more

Exercise Testing After Preeclampsia

NCT06741436 · Preeclampsia, Heart Failure Preserved Ejection Fraction, and more

Molecular Study of the Maternal-fetal Interface in Preeclampsia.

NCT06232668 · Preeclampsia

Prevention of Preeclampsia in Denmark: A National Implementation Study

NCT07485140 · Preeclampsia (PE)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 31, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment72

Start dateJul 2023

Last updatedMar 31, 2026

Condition

HELLP Syndrome Preeclampsia

Locations shown

CHU Mohammed VI of Marrakech

Marrakesh, Marrakesh-Safi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 31, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions